BamSEC and AlphaSense Join Forces
Learn More

Windtree Therapeutics Inc.

NASDAQ: WINT    
Share price (12/20/24): $0.32    
Market cap (12/20/24): $2.879 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 32 pages Windtree Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 34 pages Windtree Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 36 pages Windtree Therapeutics, Inc. Senior Secured Note
12/34/56
EX-4.1
from 8-K 29 pages Windtree Therapeutics, Inc. Senior Unsecured Promissory Note
12/34/56
EX-4.2
from 8-K 35 pages Windtree Therapeutics, Inc. Senior Secured Note
12/34/56
EX-4.1
from 8-K 8 pages Convertible Promissory Note
12/34/56
EX-4.18
from 10-K 2 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 52 pages Windtree Therapeutics, Inc. Senior Convertible Note
12/34/56
EX-4.1
from 8-K 33 pages Windtree Therapeutics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of April 24, 2023 Warrant Agency Agreement
12/34/56
EX-4.21
from S-1/A 14 pages Windtree Therapeutics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of , 2023 Warrant Agency Agreement
12/34/56
EX-4.20
from S-1/A 20 pages Pre-Funded Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.19
from S-1/A 21 pages Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 20 pages Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.12
from S-3 21 pages Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.3
from S-3 41 pages Windtree Therapeutics, Inc. Indenture Dated as of [●], 20[●] [●] Trustee
12/34/56
EX-4.16
from 10-K 2 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 14 pages Windtree Therapeutics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of March 25, 2021 Warrant Agency Agreement
12/34/56
EX-4.1
from 8-K 21 pages Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.6
from S-8 4 pages Windtree Therapeutics, Inc. 2020 Equity Incentive Plan Stock Option Grant Notice and Stock Option Agreement
12/34/56